December 8, 2025

Men and women may need different medications to avoid broken bones

December 8, 2025 / Research update / InnovateMed Author / broken bones

by Kate Carthew, Monash University edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain A new international study published in Osteoporosis International and led by Monash’s Center for Medicine Use and Safety (CMUS) has investigated the risks of a second hip fracture, subsequent fractures, and death in people prescribed two different classes of bone strengthening medications. The […]

Men and women may need different medications to avoid broken bones Read More »

Dopamine neurons also work while you sleep to strengthen skills, study reveals

December 8, 2025 / Research update / InnovateMed Author / dopamine

by Jared Wadley, University of Michigan edited by Lisa Lock, reviewed by Robert Egan Editors’ notes VTADA neuronal activity during NREM sleep is modulated by enriched multisensory salient experiences but not by predator-related salient experiences. Credit: Science Advances (2025). DOI: 10.1126/sciadv.adw7427 Dopamine neurons—the cells that drive reward and motivation while we’re awake—become surprisingly active during nonrapid eye movement sleep right after

Dopamine neurons also work while you sleep to strengthen skills, study reveals Read More »

Excessive heat harms young children’s development, study suggests

December 8, 2025 / Research update / InnovateMed Author / excessive heat

by New York University edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain Climate change—including high temperatures and heat waves—has been shown to pose serious risks to the environment, food systems, and human health, but new research finds that it may also lead to delays in early childhood development. Published in the Journal of

Excessive heat harms young children’s development, study suggests Read More »

Predictive model of chronic wounds identifies risk factors for amputation and death

December 8, 2025 / Clinical Practice / InnovateMed Author / chronic wound

by Regenstrief Institute edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain Chronic wounds affect thousands of patients each year and can lead to serious complications, including amputation and death. The Regenstrief Institute Chronic Wound Registry, a statewide database that collects real-world clinical data from hospitals and outpatient clinics across Indiana, allows researchers

Predictive model of chronic wounds identifies risk factors for amputation and death Read More »

Those who care for family members with Alzheimer’s experience poorer health and increased cellular aging

December 8, 2025 / Research update / InnovateMed Author / alzheimer

by Tony Van Witsen, Emory University edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain Brittany Butts understands that for many families, Alzheimer’s comes as a double burden. As a teenager, she watched not only her grandmother’s mental decline from the disease but also her aunt’s struggles as the primary caregiver. “When I

Those who care for family members with Alzheimer’s experience poorer health and increased cellular aging Read More »

Fish oil supplement halves serious cardiovascular events in patients on dialysis, clinical trial finds

December 8, 2025 / Research update / InnovateMed Author / fish oil supplement

by Monash University edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Credit: Pixabay/CC0 Public Domain A daily fish oil supplement has been shown to significantly reduce serious cardiovascular events in people receiving dialysis for kidney failure. The findings come from a major international clinical trial co-led in Australia by Monash Health and the School of Clinical

Fish oil supplement halves serious cardiovascular events in patients on dialysis, clinical trial finds Read More »

Childhood cancer catalog opens door to pediatric immunotherapy

December 8, 2025 / Clinical Practice / InnovateMed Author / cancer

by Rob Clancy, Hudson Institute of Medical Research edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Credit: iScience (2025). DOI: 10.1016/j.isci.2025.113887 A unique facility in Melbourne containing hundreds of childhood cancer tissue samples has produced a first-of-its-kind catalog of pediatric cancers to help identify how the immune system can target each one. Pediatric cancer is the leading cause

Childhood cancer catalog opens door to pediatric immunotherapy Read More »

Unexplained Pediatric Mucositis: Could It Be RIME?

December 8, 2025 / Clinical Practice / InnovateMed Author / mucositis

Doug Brunk November 11, 2025 SAN ANTONIO — When a child presents with mucositis of two or more sites with no prescription drug history, think reactive infectious mucocutaneous eruption (RIME). RIME usually occurs after a bacterial or viral respiratory infection and is most often seen in children and adolescents, although it can also affect adults,

Unexplained Pediatric Mucositis: Could It Be RIME? Read More »

Infectious Diseases Update: Measles, Hand-Foot-Mouth Disease Rates Increasing

December 8, 2025 / Clinical Practice / InnovateMed Author / infectious disease

Heidi Splete November 17, 2025 Although the CDC reports that the fall flu season in the US is currently mild, measles and hand-foot-mouth disease (HFMD) are surging this fall, according to recent data from Epic Research. Getting a Handle on HFMD The weekly medically attended HFMD rate in October more than tripled from the highest weekly rate

Infectious Diseases Update: Measles, Hand-Foot-Mouth Disease Rates Increasing Read More »

For Moderate-to-Severe Psoriasis, Novel Oral Therapy Acts Like a Biologic in Phase 3 Trial

December 8, 2025 / Research update / InnovateMed Author / psoriasis

Ted Bosworth November 12, 2025 Icotrokinra, a novel oral interleukin (IL)-23 inhibitor, provided a level of response in moderate-to-severe plaque psoriasis that is similar to that previously reported with injectable biologics, according to 16-week results from a newly published phase 3 trial. In a population with a median baseline Psoriasis Area and Severity Index (PASI)

For Moderate-to-Severe Psoriasis, Novel Oral Therapy Acts Like a Biologic in Phase 3 Trial Read More »